Healthcare

Resmed's Evolving Journey in Sleep Health and Digital Care

Resmed's Evolving Journey in Sleep Health and Digital Care

EZZ Life Science Experiences Significant Growth with Record-Breaking...

Highlights,EZZ Life Science recorded substantial revenue growth in the first half of the fiscal year, demonstrating strong financial performance.,Expa...

Biotech Ventures Eye Expansive Growth Amid Approvals and Strategic S...

Highlights,Telix Pharmaceuticals (ASX:TLX) anticipates significant revenue growth following upcoming FDA approvals for innovative imaging products in...

Is Paragon Care Limited (ASX:PGC) Accurately Priced in the Market?

Highlights:,Paragon Care (ASX:PGC) appears to be overvalued by approximately 23%.,Industry peers of PGC are currently trading at a significant discoun...

Is Argenica Therapeutics Managing Cash Burn Effectively?

Highlights:,Argenica Therapeutics (ASX:AGN) has a solid cash runway of over three years.,Cash burn increased significantly last year, rising by more t...

Has Bioxyne's Impressive Growth Signal a New Era for the Company?

Highlights:,Bioxyne's stock has surged significantly over the past year.,Revenue growth has been a key factor behind the strong share performance.,Des...

Tariff Pressures Forecast to Increase Costs for Fisher & Paykel (ASX...

Highlights,Tariffs imposed on Mexico are,anticipated,to elevate manufacturing costs in FY26.,Approximately 50% of manufacturing occurs in Mexico and 5...

Innovative GI Imaging Trial in Germany Paves the Way for Next-Genera...

Highlights,Pre-Clinical Initiative:,A pre-clinical study has been launched at the University Medical Centre of the Johannes Gutenberg University in Ma...

Is Paradigm Biopharmaceuticals Making Progress with its Osteoarthrit...

Highlights:,Paradigm Biopharmaceuticals (ASX:PAR) partners with Advanced Clinical for the PARA_OA_012 phase III osteoarthritis trial.,Advanced Clinica...

Is the Biotech Sector on the Verge of a Major Breakthrough?

Highlights:,Emyria's MDMA Trial Shows Lasting PTSD Relief,: Emyria (ASX:EMD) reports its MDMA-based therapy continues demonstrating notable improvemen...

Are Biotech Companies Facing Unforeseen Hurdles?

Highlights,Percheron Therapeutics (ASX:PER) discontinues its lead candidate following a DMD trial setback.,Immutep (ASX:IMM) continues multiple clinic...

Is the Health Sciences Sector Experiencing Significant Change?

Highlights,Sigma Healthcare (ASX:SIG) to combine operations with Chemist Warehouse in a major industry realignment.,Biome Australia (ASX:BIO) secures...

Is This Quiet Stock About to Shake Up the Market?

Highlights:,Alterity Therapeutics' stock surged by 260% in the past year.,Recent capital raise strengthens the company's financial position.,Investors...

Prescient Therapeutics Gears Up for Transformative Year with New Lea...

Highlights:,New CEO James McDonnell,appointed,and FDA clearance received for PTX-100 Phase 2 clinical trial.,Successful IND application for PTX-100 Ph...

Race Oncology (ASX:RAC) Advances RC220 Phase 1 Trial and Strengthens...

Highlights,RC220 Phase 1 Trial Progress,:,Ethics and regulatory submissions completed, with first patient treatment,anticipated,in Q1 CY2025.,Leadersh...

Mesoblast (ASX:MSB) Advances Ryoncil Launch Following FDA Approval

Highlights:,Mesoblast (,ASX:MSB,) secures $260 million funding,for the commercial launch of,Ryoncil,in the US.,Ryoncil,gains FDA approval,, leading to...

ResMed Shares Surge on Q2 Earnings Report, Revenue Jumps 10%

Highlights,Revenue Growth:,ResMed posted a 10% year-over-year revenue increase to,$1.3 billion,, exceeding market expectations.,Profit Surge:,Operatin...

What’s Driving the Surge in ASX Health Stocks?

Highlights,The S&P/ASX 200 Health Care Index rose by 3.3% last week, outperforming the general market's 1.9% increase.,Microba’s quarterly sales surge...

How Are Paradigm Biopharmaceuticals' Strategic Initiatives Shaping I...

Highlights:,Paradigm Biopharmaceuticals introduces a loyalty and piggyback options offer, aimed at raising over $110 million.,Shareholders can benefit...

Steady Growth at Medical Developments International Limited (ASX:MVP...

Understanding Medical Developments International's Current Valuation